Title : The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo.

Pub. Date : 2019 Mar 7

PMID : 30845975






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo. birinapant CD47 molecule Homo sapiens
2 METHODS: Interactions between the clinically relevant IAP (inhibitor of apoptosis protein) antagonist birinapant (TL32711) and the proteasome inhibitor bortezomib were investigated in multiple myeloma (MM) cell lines and primary cells, as well as in vivo models. birinapant CD47 molecule Homo sapiens